[go: up one dir, main page]

NO20033801D0 - Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser - Google Patents

Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Info

Publication number
NO20033801D0
NO20033801D0 NO20033801A NO20033801A NO20033801D0 NO 20033801 D0 NO20033801 D0 NO 20033801D0 NO 20033801 A NO20033801 A NO 20033801A NO 20033801 A NO20033801 A NO 20033801A NO 20033801 D0 NO20033801 D0 NO 20033801D0
Authority
NO
Norway
Prior art keywords
prevention
treatment
psychotic disorders
carbamate compounds
carbamate
Prior art date
Application number
NO20033801A
Other languages
English (en)
Other versions
NO20033801L (no
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20033801D0 publication Critical patent/NO20033801D0/no
Publication of NO20033801L publication Critical patent/NO20033801L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20033801A 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser NO20033801L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
NO20033801D0 true NO20033801D0 (no) 2003-08-26
NO20033801L NO20033801L (no) 2003-10-22

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033801A NO20033801L (no) 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Country Status (25)

Country Link
US (1) US6541513B2 (no)
EP (1) EP1401424B1 (no)
JP (1) JP4276841B2 (no)
KR (1) KR100886578B1 (no)
CN (1) CN1262271C (no)
AR (1) AR032876A1 (no)
AT (1) ATE346597T1 (no)
AU (1) AU2002242296B2 (no)
BR (1) BR0207829A (no)
CA (1) CA2439480C (no)
CZ (1) CZ302412B6 (no)
DE (1) DE60216457T2 (no)
DK (1) DK1401424T3 (no)
ES (1) ES2275844T3 (no)
HU (1) HUP0303342A3 (no)
IL (2) IL157588A0 (no)
MX (1) MXPA03007722A (no)
NO (1) NO20033801L (no)
NZ (1) NZ527991A (no)
PL (1) PL365021A1 (no)
PT (1) PT1401424E (no)
RS (1) RS51056B (no)
RU (1) RU2302240C2 (no)
TW (1) TWI251486B (no)
WO (1) WO2002067927A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7349301A (en) * 2000-07-21 2002-02-05 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
RS51055B (sr) * 2001-02-27 2010-10-31 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja
MXPA03007720A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
ATE435014T1 (de) 2001-07-16 2009-07-15 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
EA019935B1 (ru) * 2005-07-26 2014-07-30 Янссен Фармацевтика Н.В. Способы лечения алкогольной абстиненции
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
US20080103199A1 (en) * 2006-10-31 2008-05-01 Haas Magali Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
US9566261B2 (en) 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
DK0480939T3 (da) * 1989-06-09 1995-07-10 Upjohn Co Heterocycliske aminer med virkning på centralnervesystemet
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
JP2004523556A (ja) 2004-08-05
EP1401424B1 (en) 2006-11-29
TWI251486B (en) 2006-03-21
DE60216457T2 (de) 2007-09-20
US6541513B2 (en) 2003-04-01
WO2002067927A1 (en) 2002-09-06
PT1401424E (pt) 2007-02-28
EP1401424A1 (en) 2004-03-31
PL365021A1 (en) 2004-12-27
RU2003128983A (ru) 2005-03-10
HUP0303342A2 (hu) 2004-01-28
US20020165272A1 (en) 2002-11-07
CA2439480C (en) 2011-04-26
CN1262271C (zh) 2006-07-05
RS67503A (sr) 2006-12-15
MXPA03007722A (es) 2004-11-12
KR100886578B1 (ko) 2009-03-05
IL157588A0 (en) 2004-03-28
KR20030076713A (ko) 2003-09-26
HUP0303342A3 (en) 2012-07-30
DK1401424T3 (da) 2007-02-26
JP4276841B2 (ja) 2009-06-10
ES2275844T3 (es) 2007-06-16
RS51056B (sr) 2010-10-31
CZ20032297A3 (cs) 2004-06-16
DE60216457D1 (de) 2007-01-11
IL157588A (en) 2009-12-24
CZ302412B6 (cs) 2011-05-04
BR0207829A (pt) 2004-06-22
NO20033801L (no) 2003-10-22
ATE346597T1 (de) 2006-12-15
NZ527991A (en) 2005-04-29
AU2002242296B2 (en) 2006-06-29
CN1505507A (zh) 2004-06-16
AR032876A1 (es) 2003-11-26
RU2302240C2 (ru) 2007-07-10
CA2439480A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
DK1446122T5 (da) Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
NO20033803L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bevegelseslidelser
NO20035522D0 (no) Kinuklidin-substituerte multisykliske heteroaryler for behandling av sykdom
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
NO20033798D0 (no) Karbamatforbindelser for bruk ved prevensjon eller terapi av neurodegenerative lidelser
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20052626D0 (no) Middel for forhindring eller behandling av neuropati
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
NO20033417D0 (no) Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser
NO20033801D0 (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
NO20054913D0 (no) Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
EP1461030A4 (en) AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
NO20042965L (no) Flytende anlegg for behandling av hydrokarboner
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application